182 related articles for article (PubMed ID: 17503439)
1. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Linja MJ; Savinainen KJ; Saramäki OR; Tammela TL; Vessella RL; Visakorpi T
Cancer Res; 2001 May; 61(9):3550-5. PubMed ID: 11325816
[TBL] [Abstract][Full Text] [Related]
3. Screening of genetic and expression alterations of SRC1 gene in prostate cancer.
Mäki HE; Waltering KK; Wallén MJ; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Visakorpi T
Prostate; 2006 Sep; 66(13):1391-8. PubMed ID: 16894533
[TBL] [Abstract][Full Text] [Related]
4. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
Miyoshi Y; Ishiguro H; Uemura H; Fujinami K; Miyamoto H; Miyoshi Y; Kitamura H; Kubota Y
Prostate; 2003 Sep; 56(4):280-6. PubMed ID: 12858356
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer.
Koivisto PA; Rantala I
J Pathol; 1999 Jan; 187(2):237-41. PubMed ID: 10365100
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor gene mutations in hormone-refractory prostate cancer.
Wallén MJ; Linja M; Kaartinen K; Schleutker J; Visakorpi T
J Pathol; 1999 Dec; 189(4):559-63. PubMed ID: 10629558
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
[TBL] [Abstract][Full Text] [Related]
8. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Porkka KP; Tammela TL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
10. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
11. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Koivisto P; Kononen J; Palmberg C; Tammela T; Hyytinen E; Isola J; Trapman J; Cleutjens K; Noordzij A; Visakorpi T; Kallioniemi OP
Cancer Res; 1997 Jan; 57(2):314-9. PubMed ID: 9000575
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma.
Koivisto PA; Helin HJ
J Pathol; 1999 Oct; 189(2):219-23. PubMed ID: 10547578
[TBL] [Abstract][Full Text] [Related]
14. Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
Waltering KK; Wallén MJ; Tammela TL; Vessella RL; Visakorpi T
Prostate; 2006 Nov; 66(15):1585-91. PubMed ID: 16927275
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
16. Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers.
Krajewska M; Turner BC; Shabaik A; Krajewski S; Reed JC
Prostate; 2006 Jun; 66(8):801-10. PubMed ID: 16482527
[TBL] [Abstract][Full Text] [Related]
17. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
[TBL] [Abstract][Full Text] [Related]
18. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y
Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
Haapala K; Kuukasjärvi T; Hyytinen E; Rantala I; Helin HJ; Koivisto PA
Hum Pathol; 2007 Mar; 38(3):474-8. PubMed ID: 17217995
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.
Brown RS; Edwards J; Dogan A; Payne H; Harland SJ; Bartlett JM; Masters JR
J Pathol; 2002 Oct; 198(2):237-44. PubMed ID: 12237884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
